摘要
背景:维甲酸外用的临床疗效已被广泛研究,并已被广泛应用于许多治疗措施,其中包括光老化、痤疮和黄褐斑。然而,IDE效应,主要是皮肤刺激,红斑,干燥和脱皮,仍然是患者依从性的主要障碍。此外,对药物释放状况的洞察力对于忍受药物的治疗作用。 方法:通过数据库中的文献研究,重点介绍维A酸载体系统的进一步进展和最新进展,如脂质体、固体脂质纳米颗粒、纳米李分子等。PID载体,环糊精,纳米结构聚合物和其他技术系统,以减少其副作用和改善渗透剖面,以提高药效和药物安全性。 结果:研制了猪耳、蛇、小鼠和人皮肤体外通透性模型,并对药物制剂进行了评价,并对其刺激性进行了验证。维甲酸的租赁制度及与现有商业制剂的比较。总体结果表明,系统的组成、电荷和大小对维甲酸的释放有影响,对t有调节作用。他的释放类型和它的保留。小的单层囊泡促进了维甲酸的更大的皮肤输送。负电荷对脂质体和硝基苯体都有促进猪皮水化的作用。Ell作为维甲酸的保留物。固体脂质含量和固体脂质纳米粒和纳米脂质载体组成中所使用的油脂种类对经皮药物剥离有影响。[医] 丹毒丝菌属 结论:从文献中可以清楚地看出,维甲酸技术给药系统是一种创新和潜在的管理方法,以提高患者的依从性、安全性和有效性。calcyclin 钙细胞周期蛋白.
关键词: 维甲酸,局部给药,纳米技术,副作用,维甲酸释放,体外渗透。
Current Medicinal Chemistry
Title:Nanotechnological Advances for Cutaneous Release of Tretinoin: An Approach to Minimize Side Effects and Improve Therapeutic Efficacy
Volume: 25 Issue: 31
关键词: 维甲酸,局部给药,纳米技术,副作用,维甲酸释放,体外渗透。
摘要: Background: The clinical efficacy of the topical tretinoin is widely studied and has been well established for many therapeutic interventions, among some, photoaging, acne, and melasma. However, the side effects, mainly cutaneous irritation, erythema, xerosis and peeling, remain major obstacle to the patient compliance. Besides, the insight regarding the drug delivery profile is essential to understand the therapeutic action of the drug.
Methods: Through bibliographic research in databases we highlight further advances and an update on tretinoin delivery systems such as liposomes, niosomes, solid lipid nanoparticles, nanostructured lipid carriers, cyclodextrins, nanostructured polymers and other technological systems that reduce its side effects and improve the permeation profile to potentiate efficacy and drug safety on the skin.
Results: Pharmaceutical preparations were developed and evaluated for permeability in in vitro models using pig ear, snake, mouse and human skin, and potential for irritation was also verified using release systems for tretinoin and compared to available commercial formulations. Overall results indicated the composition, charge and size of the system influences the tretinoin delivery, modulating the type of release and its retention. Small unilamellar vesicles promoted greater cutaneous delivery of tretinoin. Negative charge, for both liposomes and niosomes, can improve pig skin hydration as well as the tretinoin retention. The quantity of solid lipids and the type of oil used in the composition of solid lipid nanoparticles and nanostructured lipid carriers affected percutaneous drug delivery.
Conclusion: As evident from the literature, the tretinoin technological delivery systems consist an innovative and potential management for increasing the patient compliance presenting safety and efficacy.
Export Options
About this article
Cite this article as:
Nanotechnological Advances for Cutaneous Release of Tretinoin: An Approach to Minimize Side Effects and Improve Therapeutic Efficacy, Current Medicinal Chemistry 2018; 25 (31) . https://dx.doi.org/10.2174/0929867325666180313110917
DOI https://dx.doi.org/10.2174/0929867325666180313110917 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
CYP3A4-mediated Pharmacokinetic Interactions in Cancer Therapy
Current Drug Metabolism Traditional Chinese Medicine Remedy to Jury: The Pharmacological Basis for the Use of Shikonin as an Anticancer Therapy
Current Medicinal Chemistry Therapeutic Exploitation of Endogenous Anti-Inflammatory Mechanisms:Old and New Leads
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Integrated Development of Chemoptical Fiber Nanosensors
Current Analytical Chemistry Deciphering Signaling Control by Phosphoproteome Using Mass Spectrometry
Protein & Peptide Letters Drug-Membrane Interactions: Significance for Medicinal Chemistry
Current Medicinal Chemistry Human Hepatocytes in Primary Culture: The Choice to Investigate Drug Metabolism in Man
Current Drug Metabolism β-Galactosylated Alkyl-oligoamine Derivatives of Polyethylenimine Enhanced pDNA Delivery into Hepatic Cells with Reduced Toxicity
Current Nanoscience Metabolomics of Serum Peptides
Protein & Peptide Letters Antibody Recognition of Fluorinated Haptens and Antigens
Current Topics in Medicinal Chemistry Nanoparticle-Based Therapy in Genomics
Current Drug Metabolism Synthesis of Some New Chromeno[2,3-b]pyridine and [1,2,4]Triazolo[1,5- a]quinoline Nucleoside Analogues with Expected Biological Activity
Letters in Organic Chemistry Antioxidants in Health, Disease and Aging
CNS & Neurological Disorders - Drug Targets Coumarins as Potential Inhibitors of DNA Polymerases and Reverse Transcriptases. Searching New Antiretroviral and Antitumoral Drugs
Current Drug Discovery Technologies To Analyze the Amelioration of Phenobarbital Induced Oxidative Stress by Erucin, as Indicated by Biochemical and Histological Alterations
Anti-Cancer Agents in Medicinal Chemistry Analyzing LC/MS Metabolic Profiling Data in the Context of Existing Metabolic Networks
Current Metabolomics Pharmacokinetic Mechanisms for Reduced Toxicity of Irinotecan by Coadministered Thalidomide
Current Drug Metabolism The Treatment of Painful Diabetic Neuropathy
Current Diabetes Reviews Polymeric Micelles for Ocular Delivery: Progress and Issues
Pharmaceutical Nanotechnology Endocannabinoid System in Neurological Disorders
Recent Patents on CNS Drug Discovery (Discontinued)